NORTHSHORE UNIVERSITY HEALTHSYSTEM
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $33.9M
- Transactions
- 7,931
- Companies
- 40
- Average per transaction
- $4,269
Who reported the payments
| Merck | $1,709,988 |
| Pfizer | $1,620,712 |
| Abbott | $1,363,338 |
| Novo Nordisk AS | $1,199,283 |
| Amgen | $1,149,014 |
| Boston Scientific | $1,135,042 |
| Edwards Lifesciences | $1,127,035 |
| Incyte Corporation | $1,012,468 |
| Argenx US, Inc. | $985,441 |
| UCB SA | $978,853 |
| Intuitive Surgical | $972,306 |
| Eli Lilly | $952,608 |
| AbbVie | $908,682 |
| Janssen Research & Development, LLC | $887,668 |
| Alnylam Pharmaceuticals Inc. | $869,303 |
| Baxter Healthcare | $832,676 |
| Sanofi US Services Inc. | $781,531 |
| Medtronic | $748,418 |
| KARL Storz Endoscopy-america | $725,246 |
| Takeda Pharmaceuticals U.S.A., Inc. | $571,278 |
| Roche Molecular Systems, Inc. | $563,795 |
| Novartis | $535,747 |
| Siemens Medical Solutions USA, Inc. | $486,817 |
| Regeneron | $467,726 |
| H. Lundbeck A S | $457,246 |
| BD | $455,146 |
| AstraZeneca | $451,116 |
| E.r. Squibb & Sons, L.L.C. | $446,934 |
| Genentech, Inc. | $427,834 |
| Daiichi Sankyo Inc. | $421,862 |
| Luminex Corporation | $410,314 |
| GE HealthCare | $376,382 |
| Boehringer Ingelheim | $348,943 |
| Gilead | $333,272 |
| Medline Industries LP | $331,363 |
| Blue Earth Diagnostics | $300,417 |
| Medical Device Business Services, Inc. | $272,247 |
| Biosense Webster, Inc. | $269,729 |
| Eagle Pharmaceuticals, Inc. | $234,215 |
| Jan Medical Inc. | $210,907 |